Bainan Biotech ApS: Financial statements 2023
CVR: 39904276
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Bainan Biotech ApS (CVR 39904276) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -382,113 and a net result of DKK -2,671,977 compared with DKK -3,128,882 the year before. Equity in the 2023 report amounted to DKK -15,215,743. The company had 1 employee in the financial year.
- Gross Profit
- DKK -382,113
- Profit/Loss
- DKK -2,671,977
- Equity
- DKK -15,215,743
- Total Assets
- DKK 2,917,032
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -382 t. | -2.7 mio. | -15.2 mio. | 1 |
| 2022 | - | -1.2 mio. | -3.1 mio. | -12.5 mio. | 4 |
| 2021 | - | -3.7 mio. | -9.1 mio. | -9.4 mio. | 9 |
| 2020 | - | 2 mio. | -510 t. | -351 t. | 1 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Bainan Biotech ApS has published its annual report for 2022. Gross profit came to DKK -1,230,180, and the net result was DKK -3,128,882.
As of June 29, 2023, Bolette Hartmann is registered as adm. dir. of Bainan Biotech ApS.
As of June 29, 2023, Tue Alexander Emborg has stepped down as adm. dir. of Bainan Biotech ApS.
As of June 1, 2023, Tue Alexander Emborg is registered as adm. dir. of Bainan Biotech ApS.
As of June 1, 2023, Bolette Hartmann has stepped down as adm. dir. of Bainan Biotech ApS.
As of May 15, 2023, Arvind Mansha Hundal has left the board of directors of Bainan Biotech ApS.
About Bainan Biotech ApS
Bainan Biotech ApS was a Danish company of the type Anpartsselskab based in København N, founded in 2018. The company has been dissolved on 20 July 2026. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company has 2 employees (2024). In 2023, the company reported a gross profit of DKK -382,113 and a net result of DKK -2,671,977 compared with DKK -3,128,882 the year before. Equity in the 2023 report amounted to DKK -15,215,743.